Dubois B et al (2016) Preclinical Alzheimers disease: definition, natural history, and diagnostic criteria
When used along with healthy eating, regular exercise, and a dedication to long-term changes, they can make a positive difference in a person's life
Zinke , in which that court treated a similar factual finding about elephant trophies as rulemaking

Vodcast Series Putting evidence into practice: Tips for starting and continuing GLP-1 RAs Claim CE Credit Episode 7: Barriers to GLP-1 RAs Claim CE and MOC Credit Selecting the Right Patient at the Right Time Claim CE Credit Practical Pointers to Optimize the Use of GLP-1 RAs Claim CE Credit Chronic Kidney Disease and GLP-1 RAs Cardiovascular Benefits of GLP-1 RAs Claim CE and MOC Credit Demystifying GLP-1s Claim CE and MOC Credit Obesity and GLP-1 RAs Claim CE Credit Guidelines and Articles 2021 Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Hart Association/American Stroke Association | Stroke 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes | Circulation Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Assocation | Circulation References 1 Arnett DK, Blumenthal RS, Albert MA, et al
)
Although patent protection lapsed in 2019, various settlement agreements continued to moderate generic impact, with increased generic volumes in 2025 contributing to a sharper slowdown in growth prior to unrestricted competition in 2026